Hokuyaku Takeyama Holdings,Inc. (SPSE: 3055)

Market Cap	17.93B
Revenue (ttm)	280.69B
Net Income (ttm)	2.33B
Shares Out	21.02M
EPS (ttm)	108.41
PE Ratio	7.87
Forward PE	n/a
Dividend	20.00 (2.37%)
Ex-Dividend Date	Mar 28, 2025

Volume	600
Average Volume	1,120
Open	850.00
Previous Close	846.00
Day's Range	844.00 - 850.00
52-Week Range	763.00 - 1,052.00
Beta	0.22
RSI	47.87
Earnings Date	Feb 6, 2025

About Hokuyaku Takeyama Holdings,Inc.

Hokuyaku Takeyama Holdings,Inc. engages in the wholesale of pharmaceutical products in Japan. It also sells medical devices, such as treatment/facility equipment, image diagnostic equipment, optical equipment, artificial organ-related equipment, biological information-related equipment, physical therapy equipment, and examination equipment, as well as general-purpose products, such as syringes and orthopedic surgery. In addition, the company operates pharmacies in Hokkaido; and provides nursing care services, welfare equipment, care plans, day ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2006
• Employees: 1,601
• Stock Exchange: Sapporo Stock Exchange
• Ticker Symbol: 3055

Financial Performance

In 2023, Hokuyaku Takeyama Holdings,Inc.'s revenue was 275.36 billion, an increase of 5.11% compared to the previous year's 261.98 billion. Earnings were 2.18 billion, a decrease of -20.30%.